Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Tarenflurbil Fails to Meet Primary End Point in Phase 3; End of the Road for Development
Link ID 7253
Title Tarenflurbil Fails to Meet Primary End Point in Phase 3; End of the Road for Development
Url http://www.medscape.com/viewarticle/577045?src=rss
Description In a brief statement, Myriad Genetics reports that tarenflurbil failed to have a significant effect in mild AD patients in a phase 3 trial and announced that it will not continue development of the compound. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Jul 4, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Palliative Sedation Increases as Euthanasia Declines in Netherlands
  In the Netherlands, where euthanasia is legal but regulated by law, the use of continuous deep sedation for patients near death increased between 2001 and 2005, while the use of euthanasia declined. Reuters Health Information
Category:   Articles > Business of Medicine


2. Kidney Racket Scandal in IT City Shocks India
  The uncovering of an illegal kidney transplant racket in a booming information technology (IT) city has gripped India, with reports hundreds of poor labourers may have been duped or forced into donating organs to wealthy clients, including foreigners. Reuters Health Information
Category:   Articles > Business of Medicine


3. Avoid Chinese-Made Baby Formula, U.S. FDA Says
  Baby formula from China is illegal in the United States and should not be used, U.S. regulators warned on Thursday after Chinese officials blamed tainted formula for the death of an infant. Reuters Health Information
Category:   Articles > Business of Medicine


4. Strides Arcolab Gets U.S. FDA Nod for 2 More Products
  Strides Arcolab Ltd said on Tuesday it has got approval from the U.S. Food and Drug Administration for two more drugs, thereby taking the total approvals to 11. Reuters Health Information
Category:   Articles > Business of Medicine


5. Medicare Underestimated Improper Payments: Report
  Medicare officials had undervalued the amount of improper payments made for medical equipment in 2006 because it failed to review sufficient medical documents, according to a government report. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS